# StemCyte, Inc – FDA Inspection, Mar 24, 2026

Source: https://www.keypedia.com/records/fda_inspections/stemcyte-inc/fe5f8458-e932-47ff-a32a-9ff2060b47b0
Source feed: FDA_Inspections

> FDA inspection 1291150 of StemCyte, Inc, March 24, 2026. 8 citations under 21 CFR parts 211 and 1271. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291150
- Company Name: StemCyte, Inc
- Inspection Date: 2026-03-24
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 8

## Related Documents

- FDA Inspection 1101775 - 2019-07-31
- [FDA Inspection 821099 - 2013-03-12](https://www.keypedia.com/records/fda_inspections/stemcyte-inc/9e207d14-46c2-4b4c-88d8-ef7c1db86ae9)
- FDA Inspection 736757 - 2011-07-28
- [FDA Inspection 643295 - 2010-02-11](https://www.keypedia.com/records/fda_inspections/stemcyte-inc/2097e50c-919e-462b-86be-7efda227177e)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/celeta-s-coves/d0f63577-a6e4-4872-b06c-a024188a04ba)
- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)
- [FDA Associated Person](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)

Company: https://www.keypedia.com/companies/stemcyte-inc/8d9f9d48-8d24-4ba3-8af0-707de0bb4595

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b